Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 241 Lymphoma 178 Lymphoma, Large B-Cell, Diffuse 172 Precursor Cell Lymphoblastic Leukemia-Lymphoma 88 Lymphoma, Follicular 79 Lymphoma, Non-Hodgkin 73 Burkitt Lymphoma 66 Multiple Myeloma 64 Leukemia 58 Hodgkin Disease 45 Lymphoma, Mantle-Cell 41 Neoplasms 35 Lymphoma, T-Cell, Peripheral 31 Lymphoma, B-Cell 30 Lymphoma, B-Cell, Marginal Zone 28 Lymphoma, Large-Cell, Anaplastic 26 Neoplasm Metastasis 25 Lymphoma, Large-Cell, Immunoblastic 24 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia, Lymphocytic, Chronic, B-Cell 22 Neoplasms, Plasma Cell 21 Recurrence 20 Immunoblastic Lymphadenopathy 15 Dendritic Cell Sarcoma, Interdigitating 15 Lymphoma, T-Cell 14 Leukemia, Biphenotypic, Acute 10 Waldenstrom Macroglobulinemia 9 Blast Crisis 9 Primary Myelofibrosis 8 Myelodysplastic Syndromes 8

Interventions

pembrolizumab 2 perflutren 1 Vinorelbine 1 Thoracoscopy 1 Surveys and Questionnaires 1 Sulfur Hexafluoride 1 Radiotherapy 1 Prednisone 1 Pemetrexed 1 Paclitaxel 1 Observation 1 Nivolumab 1 Lidocaine 1 Lenalidomide 1 Immune Checkpoint Inhibitors 1 Hypnosis 1 Health Records, Personal 1 Gemcitabine 1 Drug Therapy 1 Drug Delivery Systems 1 Dexamethasone 1 Conscious Sedation 1 Clinical Protocols 1 Carboplatin 1 Bronchoscopy 1 Bronchoalveolar Lavage 1 Blood Pressure 1 Bevacizumab 1 Behavior Therapy 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases, Interstitial × Prednisone × Clear all

NCT04036721 2023-02-23

PROS-CONS

National Institute for Tuberculosis and Lung Diseases, Poland

Phase 4 Suspended

Lung Neoplasms, Pneumonia, Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡